Shares of Carmell Co. (NASDAQ:CTCX – Get Free Report) fell 8.5% during trading on Friday . The stock traded as low as $0.19 and last traded at $0.19. 385,686 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 3,037,237 shares. The stock had previously closed at $0.21.
Carmell Trading Down 8.5 %
The business’s fifty day moving average is $0.32 and its two-hundred day moving average is $0.34.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Carmell stock. Antara Capital LP purchased a new position in shares of Carmell Co. (NASDAQ:CTCX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 100,000 shares of the company’s stock, valued at approximately $28,000. Carmell makes up approximately 0.0% of Antara Capital LP’s holdings, making the stock its 10th biggest holding. Antara Capital LP owned approximately 0.48% of Carmell at the end of the most recent quarter. Institutional investors own 24.22% of the company’s stock.
About Carmell
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Articles
- Five stocks we like better than Carmell
- How to buy stock: A step-by-step guide for beginners
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Investing in Construction Stocks
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.